IGEM-Ch

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIGEM-Ch
Drug Alias Namechondroitin sulphate proteoglycan-4 inhibiting immunoglobulin E antibodies (IGEM)CSPG-4 inhibiting IgE antibodies (IGEM)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionChondroitin sulfate proteoglycan 4 inhibitors
TargetsChondroitin sulfate proteoglycan 4
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpsilogen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpsilogen Ltd
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A